Hypermethylation of collagen α2 (I) gene (COL1A2) is an independent predictor of survival in head and neck cancer

Cancer Biomarkers

Volumn 10, Issue 3-4, 2011, Pages 135-144

  Misawa, Kiyoshi ^a   Kanazawa, Takeharu ^b   Misawa, Yuki ^a   Imai, Atsushi ^a   Endo, Shiori ^a   Hakamada, Katsura ^a   Mineta, Hiroyuki ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

5 azacytidine; COL1A2; CpG island; DNA methylation; head and neck cancer

Indexed keywords

CADHERIN; COLLAGEN; COLLAGEN ALPHA2; DEATH ASSOCIATED PROTEIN KINASE; H CADHERIN; PROTEIN P16; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CPG ISLAND; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DNA METHYLATION; EPIGENETICS; FEMALE; GENDER; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SMOKING; SQUAMOUS CELL CARCINOMA; STABLE EXPRESSION; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL LINE; CELL LINE, TUMOR; COLLAGEN TYPE I; CPG ISLANDS; DISEASE-FREE SURVIVAL; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84862870797     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2012-0242     Document Type: Article

References (37)

1. E.E. Vokes, R.R. Weichselbaum, S.M. Lippman and W.K. Hong, Head and neck cancer, N Engl J Med 328 (1993), 184-194.
2. B. Kumar, K.G. Cordell, J.S. Lee, F.P. Worden, M.E. Prince, H.H. Tran, G.T.Wolf, S.G. Urba, D.B. Chepeha, T.N. Teknos, A. Eisbruch, C.I. Tsien, J.M. Taylor, N.J. D'Silva, K. Yang, D.M.Kurnit, J.A. Bauer, C.R. Bradford and T.E.Carey, EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer, J Clin Oncol 26 (2008), 3128-3137.
3. A. Forastiere, W. Koch, A. Trotti and D. Sidransky, Head and neck cancer, N Engl J Med 345 (2001), 1890-1900. (Pubitemid 33716564)
4. M. Rodriguez-Paredes and M. Esteller, Cancer epigenetics reaches mainstream oncology, Nat Med 17 (2011), 330-339.
5. T.S. Wong, M.W. Man, A.K. Lam, W.I. Wei, Y.L. Kwong and A.P. Yuen, The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR, Eur J Cancer 39 (2003), 1881-1887. (Pubitemid 37311184)
6. M. Hasegawa, H.H. Nelson, E. Peters, E. Ringstrom, M. Posner and K.T. Kelsey, Patterns of gene promoter methylation in squamous cell cancer of the head and neck, Oncogene 21 (2002), 4231-4236. (Pubitemid 34753829)
7. S.M. Dong, D.I. Sun, N.E. Benoit, I. Kuzmin, M.I. Lerman and D. Sidransky, Epigenetic inactivation of RASSF1A in head and neck cancer, Clin Cancer Res 9 (2003), 3635-3640. (Pubitemid 37169228)
8. J.G. Herman, J.R. Graff, S. Myohanen, B.D. Nelkin and S.B. Baylin, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands, Proc Natl Acad Sci USA 93 (1996), 9821-9826. (Pubitemid 26296693)
9. J. Myllyharju and K.I. Kivirikko, Collagens, modifying enzymes and their mutations in humans, flies and worms, Trends Genet 20 (2004), 33-43. (Pubitemid 38032818)
10. P.K. Sengupta, J. Fargo and B.D. Smith, The RFX family interacts at the collagen (COL1A2) start site and represses transcription, J Biol Chem 277 (2002), 24926-24937. (Pubitemid 34951794)
11. M. Ponticos, D. Abraham, C. Alexakis, Q.L. Lu, C. Black, T. Partridge and G. Bou-Gharios, Col1a2 enhancer regulates collagen activity during development and in adult tissue repair, Matrix Biol 22 (2004), 619-628. (Pubitemid 38520091)
12. P.K. Sengupta, E.M. Smith, K. Kim, M.J. Murnane and B.D. Smith, DNA hypermethylation near the transcription start site of collagen alpha2(I) gene occurs in both cancer cell lines and primary colorectal cancers, Cancer Res 63 (2003), 1789-1797. (Pubitemid 36460839)
13. Y. Koga, M. Pelizzola, E. Cheng, M. Krauthammer, M. Sznol, S. Ariyan, D. Narayan, A.M. Molinaro, R. Halaban and S.M. Weissman, Genome-wide screen of promoter methylation identifies novel markers in melanoma, Genome Res 19 (2009), 1462-1470.
14. K. Mori, H. Enokida, I. Kagara, K. Kawakami, T. Chiyomaru, S. Tatarano, K. Kawahara, K. Nishiyama, N. Seki and M. Nakagawa, CpG hypermethylation of collagen type I alpha 2 contributes to proliferation and migration activity of human bladder cancer, Int J Oncol 34 (2009), 1593-1602.
15. H. Caren, A. Djos, M. Nethander, R.M. Sjoberg, P. Kogner, C. Enstrom, S. Nilsson and T. Martinsson, Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma, BMC Cancer 11 (2011), 66.
16. E.C. Schwalbe, J.C. Lindsey, D. Straughton, T.L. Hogg, M. Cole, H.Megahed, S.L. Ryan, M.E. Lusher, M.D. Taylor, R.J. Gilbertson, D.W. Ellison, S. Bailey and S.C. Clifford, Rapid diagnosis ofmedulloblastomamolecular subgroups, Clin Cancer Res 17 (2011), 1883-1894.
17. J.A. Anderton, J.C. Lindsey, M.E. Lusher, R.J. Gilbertson, S. Bailey, D.W. Ellison and S.C. Clifford, Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2, Neuro Oncol 10 (2008), 981-994.
18. L.A. Loss, A. Sadanandam, S. Durinck, S. Nautiyal, D. Flaucher, V.E. Carlton, M. Moorhead, Y. Lu, J.W. Gray, M. Faham, P. Spellman and B. Parvin, Prediction of epigenetically regulated genes in breast cancer cell lines, BMC Bioinformatics 11 (2010), 305.
19. T. Chiba, O. Yokosuka, K. Fukai, Y. Hirasawa, M. Tada, R. Mikata, F. Imazeki, H. Taniguchi, A. Iwama, M. Miyazaki, T. Ochiai and H. Saisho, Identification and investigation of methylated genes in hepatoma, Eur J Cancer 41 (2005), 1185-1194. (Pubitemid 40725578)
20. N.H. Park, B.M. Min, S.L. Li, M.Z. Huang, H.M. Cherick and J. Doniger, Immortalization of normal human oral keratinocytes with type 16 human papillomavirus, Carcinogenesis 12 (1991), 1627-1631.
21. K. Misawa, Y. Ueda, T. Kanazawa, Y. Misawa, I. Jang, J.C. Brenner, T. Ogawa, S. Takebayashi, R.A. Grenman, J.G. Herman, H. Mineta and T.E. Carey, Epigenetic inactivation of galanin receptor 1 in head and neck cancer, Clin Cancer Res 14 (2008), 7604-7613.
22. Z. Jin, Y. Cheng, A. Olaru, T. Kan, J. Yang, B. Paun, T. Ito, J.P. Hamilton, S. David, R. Agarwal, F.M. Selaru, F. Sato, J.M. Abraham, D.G. Beer, Y. Mori, Y. Shimada and S.J. Meltzer, Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors, Int J Cancer 123 (2008), 2331-2336.
23. T. Martone, A. Gillio-Tos, L. De Marco, V. Fiano, M. Maule, A. Cavalot, M. Garzaro, F. Merletti and G. Cortesina, Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas, Clin Cancer Res 13 (2007), 5089-5094. (Pubitemid 47502075)
24. H.L. Park, M.S. Kim, K. Yamashita, W. Westra, A.L. Carvalho, J. Lee, W.W. Jiang, J.H. Baek, J. Liu, M. Osada, C.S. Moon, J.A. Califano, M. Mori and D. Sidransky, DCC promoter hypermethylation in esophageal squamous cell carcinoma, Int J Cancer 122 (2008), 2498-2502. (Pubitemid 351590482)
25. C. Buttner, A. Skupin and E.P. Rieber, Transcriptional activation of the type I collagen genes COL1A1 and COL1A2 in fibroblasts by interleukin-4: analysis of the functional collagen promoter sequences, J Cell Physiol 198 (2004), 248-258. (Pubitemid 38133958)
26. M. H. Katz, Multivariable Analysis: A Practical Guide for Clinicians and PublicHealth Researchers, in: Setting up a multivariable analysis, Cambridge University Press, Cambridge, 2011, pp. 93-117.
27. J.G. Herman and S.B. Baylin, Gene silencing in cancer in association with promoter hypermethylation, N Engl J Med 349 (2003), 2042-2054. (Pubitemid 37448928)
28. D.R. Yates, I. Rehman, M.F. Abbod, M. Meuth, S.S. Cross, D.A. Linkens, F.C. Hamdy and J.W. Catto, Promoter hypermethylation identifies progression risk in bladder cancer, Clin Cancer Res 13 (2007), 2046-2053. (Pubitemid 46649871)
29. M.V. Brock, C.M. Hooker, E. Ota-Machida, Y. Han, M. Guo, S. Ames, S. Glockner, S. Piantadosi, E. Gabrielson, G. Pridham, K. Pelosky, S.A. Belinsky, S.C. Yang, S.B. Baylin and J.G. Herman, DNA methylation markers and early recurrence in stage I lung cancer, N Engl J Med 358 (2008), 1118-1128. (Pubitemid 351398486)
30. M. Esteller, Epigenetics in cancer, N Engl J Med 358 (2008), 1148-1159.
31. P.K. Sengupta, M. Ehrlich and B.D. Smith, A methylation-responsive MDBP/RFX site is in the first exon of the collagen alpha2(I) promoter, J Biol Chem 274 (1999), 36649-36655.
32. Y. Xu, P.K. Sengupta, E. Seto and B.D. Smith, Regulatory factor for X-box family proteins differentially interact with histone deacetylases to repress collagen alpha2(I) gene (COL1A2) expression, J Biol Chem 281 (2006), 9260-9270. (Pubitemid 43864641)
33. D.G. Huntsman, F. Carneiro, F.R. Lewis, P.M. MacLeod, A. Hayashi, K.G. Monaghan, R. Maung, R. Seruca, C.E. Jackson and C. Caldas, Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations, N Engl J Med 344 (2001), 1904-1909. (Pubitemid 32553359)
34. C.J. Marsit, M.R. Posner, M.D. McClean and K.T. Kelsey, Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma, Cancer 113 (2008), 1566-1571.
35. H. De Schutter, H. Geeraerts, E. Verbeken and S. Nuyts, Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only, Oncol rep 21 (2009), 507-513.
36. K.O. Toyooka, S. Toyooka, A.K. Virmani, U.G. Sathyanarayana, D.M. Euhus, M. Gilcrease, J.D. Minna and A.F. Gazdar, Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas, Cancer Res 61 (2001), 4556-4560. (Pubitemid 32685789)
37. D. Sun, Z. Zhang, N. Van do, G. Huang, I. Ernberg and L. Hu, Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker, Oral oncol 43 (2007), 82-87. (Pubitemid 46162252)